wellrank.ai
Sign In

Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

ClaudequalifiedCollected Jul 30, 2026, 09:39 UTC

Verbatim response from Claude

This is a fast-moving area, so here's an honest breakdown:

What Happened

The FDA declared the semaglutide shortage over (early 2025), meaning compounding pharmacies lost the legal right to compound copies of Ozempic/Wegovy. Many telehealth companies had to pivot quickly.

Services Still Navigating This Space

Still offering some compounded options (as of early 2025):

  • Hims & Hers - shifted toward "personalized" formulations (different dosages or added ingredients like B12/NAD)
  • LifeMD / GoRx - exploring compliant formulations
  • Mochi Health - working with compounding pharmacies on permitted variations

Important Caveats

  • Availability changes weekly - some services have paused compounded semaglutide entirely
  • "Personalized" compounds may face their own scrutiny
  • Tirzepatide (Mounjaro/Zepbound) shortage status differs - compounding may still be permitted there

My Honest Recommendation

  • Check Hims & Hers, Ro, and Mochi Health directly
  • Ask specifically about their current legal compliance approach
  • Consider services offering brand-name GLP-1s with manufacturer coupons as an alternative

Verify current status directly since this regulatory situation is actively evolving. Would you like help comparing other aspects of these services?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.